Zhongshan Hospital Fudan University

Zhongshan Hospital Fudan University: A Century of Compassion · Excellence in Medicine · Global Guardian of Health

I. Hospital Profile

Founded in 1937, Zhongshan Hospital Fudan University (referred to as “Zhongshan Hospital”) was established upon the initiative of patriotic overseas Chinese leader Mr. Tan Kah Kee and approved by the Nationalist Government. Originally named “Zhongshan Hospital,” it commemorates Dr. Sun Yat-sen's spirit of “the world for the public good.” As a Grade A tertiary general hospital directly under the National Health Commission and an affiliated hospital of Fudan University, Zhongshan Hospital upholds the motto of “Rigor, Pragmatism, Unity, and Dedication.” Over eight decades of development, it has evolved into a premier modern medical center in China and an internationally renowned institution integrating medical care, teaching, research, prevention, health preservation, and rehabilitation. It is celebrated as the “Cradle of Modern Chinese Medicine.”

Currently, Zhongshan Hospital operates across three campuses: the Main Campus (180 Fenglin Road, Xuhui District), East Campus (1988 Yunshan Road, Pudong New Area), and North Campus (921 Tongxin Road, Hongkou District). With over 3,500 open beds and an annual outpatient and emergency volume exceeding 12 million visits, it covers all disciplines including cardiovascular, hepatology, oncology, and general surgery. Its comprehensive service capabilities have consistently ranked among the top three nationally for multiple years. The hospital hosts national-level platforms including the National Clinical Research Center for Cardiovascular Diseases and the State Key Laboratory of Medical Neurobiology, maintaining industry-leading capabilities in scientific research and clinical translation.

II. Technical Advantages: Pioneering Minimally Invasive and Precision Medicine with a Focus on “Resolving Complex Cases”

Zhongshan Hospital is dual-driven by “treating complex and critical illnesses” and “pioneering technological breakthroughs,” establishing globally influential technical strengths in cardiovascular, hepatobiliary surgery, oncology, and other fields:

• Cardiovascular Field: The Department of Cardiology was among China's earliest institutions to perform interventional coronary treatments, completing over 20,000 PCI (Percutaneous Coronary Intervention) procedures annually with a success rate exceeding 98% for complex lesions (e.g., left main coronary artery, chronic total occlusion). The cardiac surgery department maintains international leadership in “off-pump coronary artery bypass grafting,” “minimally invasive valve repair,” and “heart transplantation,” with a 5-year survival rate after heart transplantation reaching 82%, ranking among the highest in Asia.

• Hepatic Surgery: Pioneering techniques like “Precision Hepatic Resection” and “ALPPS (Two-Step Hepatic Resection with Concurrent Hepatic Disconnection and Portal Vein Ligation)” are performed by our team, which conducts over 4,000 liver resections annually. The 5-year survival rate for hepatocellular carcinoma patients reaches 58% (at an internationally advanced level). Annual liver transplant volume exceeds 300 cases, with recipient 1-year survival exceeding 95%.

• Comprehensive Cancer Treatment: The Cancer Center integrates multidisciplinary resources including surgery, internal medicine, radiotherapy, and interventional therapy. It offers tumor genetic testing (e.g., liquid biopsy), immunotherapy (PD-1/CTLA-4 inhibitors), targeted therapy, and CAR-T cell therapy. Five-year survival rates for common cancers like gastric and colorectal cancer significantly exceed the national average.

• Minimally Invasive and Robotic Surgery: Departments including General Surgery, Urology, and Thoracic Surgery extensively utilize the da Vinci surgical robot for procedures such as radical prostatectomy, gastrectomy for gastric cancer, and sleeve resection for lung cancer. Annual robotic surgeries exceed 2,000 cases, offering minimally invasive techniques with rapid recovery, establishing a national-level expertise.

• Critical Care Medicine: The Emergency Medicine Department is equipped with advanced devices including ECMO (Extracorporeal Membrane Oxygenation), IABP (Intra-aortic Balloon Pump), and CRRT (Continuous Renal Replacement Therapy). The success rate for critical care interventions in severe trauma, sepsis, acute myocardial infarction, and other life-threatening conditions exceeds 91%.

III. Hospital's Leading Specialties: A “Golden Matrix” of National Key Disciplines

Zhongshan Hospital boasts 1 National Clinical Medical Research Center (Cardiovascular Diseases), 8 National Key Disciplines, and 22 National Key Clinical Specialties. The following represent its core strengths:

• Cardiovascular Medicine: Ranked second in the “Fudan China Hospital Specialty Rankings” for 15 consecutive years (first in cardiac surgery), specializing in coronary intervention, radiofrequency ablation for arrhythmias (leading globally in atrial fibrillation ablation cases), and structural heart disease (e.g., TAVI transcatheter aortic valve replacement).

• Hepatobiliary Surgery: As the “birthplace of Chinese liver surgery,” it performed China's first liver transplant and first split liver transplant. It maintains international authority in early liver cancer diagnosis (e.g., liquid biopsy) and complex liver resections (e.g., hilar cholangiocarcinoma).

• General Surgery: Specializing in gastrointestinal and pancreatic surgery, it leads nationally in minimally invasive techniques like D2 gastrectomy for gastric cancer and NOSES (Natural Orifice Specimen Extraction) for colorectal cancer. It ranks first in China for robotic-assisted gastrointestinal surgeries.

• Cardiac Surgery: China's sole institution performing “fully thoracoscopic cardiac surgery.” Minimally invasive valve repair and coronary artery bypass grafting techniques cover over 90% of cardiac procedures, with average patient hospital stays of just 5-7 days.

• Medical Oncology: Focuses on common cancers including lung, breast, and gastrointestinal tumors. Leads multiple international multicenter clinical trials, advancing precision medicine from laboratory research to clinical practice.

IV. Hospital Departments: Comprehensive Lifecycle Coverage for a One-Stop Healthcare Management System

Zhongshan Hospital maintains a robust disciplinary framework addressing the entire lifecycle from prevention and diagnosis to rehabilitation:

• Internal Medicine System: Cardiovascular Medicine (national benchmark), Gastroenterology (leading in endoscopic early cancer resection, ESD/EMR techniques), Respiratory Medicine (lung cancer targeted therapy, comprehensive pulmonary fibrosis management), Endocrinology (intensive insulin pump therapy for diabetes, thyroid nodule ablation), etc.

• Surgical System: General Surgery (minimally invasive gastrointestinal, hepatobiliary, and pancreatic surgery), Cardiothoracic Surgery (minimally invasive cardiac surgery), Hepatobiliary Surgery (precision resection for liver cancer), Urology (robot-assisted radical prostatectomy), Orthopedics (joint replacement, minimally invasive spine surgery), etc.;

• Specialty and Emergency Services: Obstetrics and Gynecology (high-risk pregnancy management, assisted reproductive technology), Pediatrics (diagnosis and treatment of congenital heart disease in children), Ophthalmology (phacoemulsification cataract surgery, myopia correction), Otolaryngology (multilevel surgery for snoring, ear microsurgery), Rehabilitation Medicine (neurological rehabilitation, postoperative functional restoration), etc.;

• Medical Technology Support: Radiology (3.0T MRI, Dual-Source CT, PET-CT for precision diagnosis), Pathology (molecular pathology testing), Laboratory Medicine (high-throughput gene sequencing), Nuclear Medicine (SPECT/CT, PET/MR imaging), providing comprehensive “one-stop” technical support for clinical practice.

V. Medical Equipment: World-Class Devices Empowering Precision Diagnosis and Treatment

Zhongshan Hospital continuously introduces globally leading medical equipment to provide hardware support for treating complex and critical conditions:

• Imaging Diagnostics: Equipped with 3.0T MRI, Dual-Source CT (enabling sub-second scanning), PET-MR (fused MRI and PET imaging), and Intraoperative MRI (real-time guidance for brain tumor surgery), achieving a 30% increase in early tumor detection rates.

• Surgery and Therapy: Da Vinci Surgical System (Xi platform) covers general surgery, urology, and thoracic surgery; Medtronic StealthStation™ Neuro Navigation assists brain tumor and spinal surgeries; interventional equipment (DSA digital subtraction angiography) supports cardiovascular, cerebrovascular, and oncology interventions.

• Critical Care and Emergency: ECMO (Extracorporeal Membrane Oxygenation), intra-aortic balloon pumps (IABP), and continuous renal replacement therapy (CRRT) machines provide life support for patients with myocardial infarction, respiratory failure, and multiple organ dysfunction.

• Laboratory Equipment: Fully automated gene sequencers (Illumina NovaSeq), flow cytometers (BD FACSymphony), mass spectrometers (SCIEX QTRAP), and more, supporting precision medicine research and clinical diagnostics.

VI. International Patient Services: Professional, Convenient, and Caring Global Healthcare

As a “Designated Foreign Medical Service Provider in Shanghai” and a “China International Medical Tourism Pilot Institution,” Zhongshan Hospital offers seamless end-to-end services for international patients:

• Multilingual Support: Professional interpreters fluent in English, Japanese, Korean, Arabic, and other languages are available in outpatient and inpatient departments. Key departments such as Cardiology and Hepatobiliary Surgery feature physicians capable of routine English communication. A 24-hour multilingual hotline is provided (+86-21-64041990 ext. International Department).

• International Medical Department (VIP Services): Dedicated private rooms (single/double occupancy with en-suite bathrooms, TV, Wi-Fi), bilingual nursing stations, customized dietary options (halal, vegetarian, etc.). Priority outpatient appointments (“green channel” for specialist consultations within 48 hours), full hospitalization assistance (including medical record translation and test scheduling).

• Visa and Insurance Assistance: Visa extension consultation for foreign patients requiring long-term treatment (coordinated with Shanghai Exit-Entry Administration Bureau); liaison with international health insurance providers (e.g., MSH, Cigna, BUPA) supporting direct billing (covering outpatient, inpatient, diagnostic, and pharmaceutical expenses).

• Cultural Adaptation Services: Religious activity rooms (Christian, Buddhist, Islamic); multilingual wayfinding signage (Chinese, English, Japanese, Korean); regular “International Patient Health Lectures” (English/Japanese) covering prevention of common diseases like cardiovascular disorders and diabetes.

VII. Global Patient Recognition: “Technical Excellence, Thoughtful Service”

• American Patient Michael (Post-Cardiac Surgery): “I required coronary artery bypass grafting for severe coronary heart disease, deemed high-risk in the U.S. Zhongshan Hospital's cardiac surgery team performed the procedure using minimally invasive techniques—I was up and walking the day after surgery! Nurses checked my recovery daily in English and even adjusted my diet to my preferences. Their medical expertise and compassionate care left me profoundly impressed.”

• Japanese Patient Yuki (Liver Surgery): “Diagnosed with advanced liver cancer, I was told surgery was impossible in Japan. Zhongshan Hospital's hepatobiliary specialists used 3D reconstruction technology for precise assessment and performed ALPPS surgery to successfully remove the tumor. One year post-op, my follow-up indicators are normal! The doctors explained every treatment step in detail in English, giving me great peace of mind.”

• German patient Thomas (General Surgery Gastrointestinal Tumor): “My gastric cancer surgery was performed at Zhongshan Hospital using robotic-assisted technology. The incision was only 5 cm, and I was discharged within a week. The International Department's translator resolved all communication issues and even recommended Shanghai's local delicacies, making me feel at home during treatment.”

VIII. Contact Information, Address & Transportation Routes

• Main Campus: 180 Fenglin Road, Xuhui District, Shanghai (near Xietu Road)

Tel: 021-64041990 (Main Switchboard); International Medical Department: 021-64041990 ext. 6000

• East Campus: 1988 Yunsan Road, Pudong New Area, Shanghai (near Biyun Road)

Tel: 021-50301990 (Main Switchboard)

• North Campus: 921 Tongxin Road, Hongkou District, Shanghai (near Lu Xun Park)

Tel: 021-56661990 (Main Switchboard)

Transportation Routes:

• Main Campus:

• Subway: Exit 1 from Hengshan Road Station (Line 1), approximately 10 minutes' walk; Exit 3 from Zhaojia浜 Road Station (Line 9), approximately 15 minutes' walk.

• Bus: Take routes 43, 50, 93, 104, etc., and get off at Fenglin Road-Xietu Road Station.

• Driving: The hospital has an underground parking garage (entrance at 170 Fenglin Road). Parking is limited on weekdays; public transportation is recommended.

• East Campus:

• Subway: Exit 2 at Yunshan Road-Biyun Road Station (Line 14), then walk about 5 minutes.

• Bus: Take Pudong Line 2 or Pudong Bus Route 5 to “Yunshan Road-Biyun Road Station.”

• By Car: The hospital features an underground parking garage (entrance at 1988 Yunshan Road) with ample parking.

Born from the flames of war in 1937 and now a “Double First-Class” medical center, Zhongshan Hospital has consistently upheld its mission of “promoting patient health and setting medical standards.” Leveraging a century of accumulated expertise, talent, and equipment, it delivers “Chinese solutions” to patients worldwide. Whether racing against the clock in cardiovascular emergencies, performing precision liver cancer surgeries, or delivering compassionate international healthcare services, Zhongshan Hospital is writing a new chapter in Chinese medicine's global advancement with an open and inclusive approach.

Document dated 2025-09-12 13:44 Modify